GAMMA Investing’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.3K Sell
7,230
-433
-6% -$2.88K ﹤0.01% 2159
2026
Q1
$41.8K Buy
7,663
+4,340
+131% +$24.4K ﹤0.01% 2303
2025
Q4
$23.3K Buy
3,323
+1,430
+76% +$11.2K ﹤0.01% 2530
2025
Q3
$14.6K Buy
1,893
+144
+8% +$1.12K ﹤0.01% 2683
2025
Q2
$15.2K Buy
1,749
+171
+11% +$1.24K ﹤0.01% 2603
2025
Q1
$12.6K Buy
1,578
+1,150
+269% +$11.6K ﹤0.01% 2630
2024
Q4
$3.89K Buy
428
+372
+664% +$3.59K ﹤0.01% 3012
2024
Q3
$514 Sell
56
-1,027
-95% -$8.5K ﹤0.01% 3390
2024
Q2
$10.6K Buy
1,083
+227
+27% +$2.77K ﹤0.01% 2219
2024
Q1
$12.9K Sell
856
-1,065
-55% -$19.3K ﹤0.01% 1909
2023
Q4
$37.3K Buy
+1,921
New +$35.4K 0.01% 1085

Other funds holding TDOC

GAMMA Investing's TDOC Position: Q2 2026 in Review

GAMMA Investing reduced its Teladoc Health (TDOC) stake by 5.7% in Q2 2026, selling an estimated $2.88K and leaving 7,230 shares worth $61.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2159.

GAMMA Investing first reported a position in TDOC in Q4 2023 and has held it in 11 quarters since. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • GAMMA Investing held 7,230 shares of Teladoc Health worth $61.3K as of Q2 2026.
  • GAMMA Investing sold 433 Teladoc Health shares in Q2 2026, an estimated $2.88K.
  • Teladoc Health made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2159 holding.
  • GAMMA Investing first reported a position in Teladoc Health in Q4 2023 and has held it in 11 quarters since.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.